CLINICAL_TRIALS
trial_result
· 2012-03-28
Clinical Trial Update: Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus [Phase 1]
Summary
A Phase 1 safety study evaluating a single-administration post-exposure prophylaxis treatment for Ebola virus disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sarepta Therapeutics, Inc. | Conditions: Ebola Hemorrhagic Fever | Phase 1 | Status: COMPLETED